The fight against metabolic and cardiovascular diseases just received a fresh infusion of capital, with Valbiotis announcing it has secured $10.9M in new funding. The commercially oriented Research & Development company specializes in developing innovative health nutrition products.
Founded in La Rochelle in early 2014, Valbiotis employs a multi-target strategy, leveraging plant-based terrestrial and marine resources to create a new class of products aimed at reducing the risk of major health conditions. The company operates from three sites in France and a subsidiary in Quebec City, Canada.
